Effect of subthalamic nucleus stimulation during exercise on the mesolimbocortical dopaminergic region in Parkinson's disease: A positron emission tomography study

Journal of Cerebral Blood Flow and Metabolism

Volumn 33, Issue 3, 2013, Pages 415-421

  Nozaki, Takao ^a   Sugiyama, Kenji ^a   Yagi, Shunsuke ^a   Yoshikawa, Etsuji ^b   Kanno, Toshihiko ^c   Asakawa, Tetsuya ^a   Ito, Tae ^a   Terada, Tatsuhiro ^a   Namba, Hiroki ^a   Ouchi, Yasuomi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Central Research Laboratory   (Japan)

^c HAMAMATSU MEDICAL CENTER   (Japan)

Author keywords

caudate; dopamine release; nucleus accumbens; Parkinson's disease; positron emission tomography; subthalamic nucleus stimulation

Indexed keywords

DOPAMINE; RACLOPRIDE C 11; SELEGILINE;

ADULT; AGED; ANKLE; ARTICLE; BINDING AFFINITY; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DORSAL ROOT; EXERCISE; FEMALE; FOOT; HUMAN; LIMBIC CORTEX; LOCOMOTION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; MOBILIZATION; MOTION; MOTIVATION; MOTOR PERFORMANCE; NEUROIMAGING; NUCLEUS ACCUMBENS; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STEREOTAXIC SURGERY; SUBTHALAMIC NUCLEUS; SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION; THALAMUS VENTRAL NUCLEUS; THERAPY EFFECT; TREATMENT DURATION; VENTRAL ROOT;

AGED; CAUDATE NUCLEUS; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINERGIC NEURONS; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; SUBTHALAMIC NUCLEUS;

EID: 84874665707     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2012.183     Document Type: Article

References (37)

1. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
2. Abosch A, Kapur S, Lang AE, Hussey D, Sime E, Miyasaki J et al. Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Neurosurgery 2003; 53: 1095-1102, discussion 1102-5.
3. Thobois S, Fraix V, Savasta M, Costes N, Pollak P, Mertens P et al. Chronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease-a [(11)C]-raclopride PET study. J Neurol 2003; 250: 1219-1223.
4. Goodman RR, Kim B, McClelland III S, Senatus PB, Winfield LM, Pullman SL et al. Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 12-17.
5. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339: 1105-1111.
6. Graybiel AM. The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 2005; 15: 638-644.
7. Packard MG, Knowlton BJ. Learning and memory functions of the basal ganglia. Annu Rev Neurosci 2002; 25: 563-593.
8. Sauleau P, Eusebio A, Vandenberghe W, Nuttin B, Brown P. Deep brain stimulation modulates effects of motivation in Parkinson's disease. Neuroreport 2009; 20: 622-626.
9. Ouchi Y, Kanno T, Okada H, Yoshikawa E, Futatsubashi M, Nobezawa S et al. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease. Brain 2001; 124(Part 4): 784-792.
10. Ouchi Y, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Sakamoto M. Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study. J Cereb Blood Flow Metab 2002; 22: 746-752.
11. Ouchi Y, Yoshikawa E, Okada H, Futatsubashi M, Sekine Y, Iyo M et al. Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: compartment analysis for beta-CFT binding with positron emission tomography. Ann Neurol 1999; 45: 601-610.
12. Mai JK, Assheuer J, Paxinos G (eds) Atlas of the Human Brain. Academic Press: San Diego, CA, 1997.
13. Klumpers UM, Veltman DJ, Boellaard R, Comans EF, Zuketto C, Yaqub M et al. Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies. J Cereb Blood Flow Metab 2008; 28: 579-587.
14. Logan J, Volkow ND, Fowler JS, Wang GJ, Dewey SL, MacGregor R et al. Effects of blood flow on [11C]raclopride binding in the brain: model simulations and kinetic analysis of PET data. J Cereb Blood Flow Metab 1994; 14: 995-1010.
15. Ouchi Y, Nobezawa S, Okada H, Yoshikawa E, Futatsubashi M, Kaneko M. Altered glucose metabolism in the hippocampal head in memory impairment. Neurology 1998; 51: 136-142.
16. FitzGerald MTJ, Folan-Curran J (eds). Clinical Neuroanatomy and Related Neuroscience. Saunders Ltd: Philadelphia, PA, USA, 2002.
17. Salamone JD, Correa M, Farrar A, Mingote SM. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology (Berl) 2007; 191: 461-482.
18. Parent A, Hazrati LN. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 1995; 20: 128-154.
19. Smith Y, Hazrati LN, Parent A. Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA-L anterograde tracing method. J Comp Neurol 1990; 294: 306-323.
20. Shu SY, Peterson GM. Anterograde and retrograde axonal transport of Phaseolus vulgaris leucoagglutinin (PHA-L) from the globus pallidus to the striatum of the rat. J Neurosci Methods 1988; 25: 175-180.
21. Hauber W. Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol 1998; 56: 507-540.
22. Ding L, Gold JI. Caudate encodes multiple computations for perceptual decisions. J Neurosci 2010; 30: 15747-15759.
23. Young AM, Joseph MH, Gray JA. Increased dopamine release in vivo in nucleus accumbens and caudate nucleus of the rat during drinking: a microdialysis study. Neuroscience 1992; 48: 871-876.
24. Mas M, Gonzalez-Mora JL, Louilot A, Sole C, Guadalupe T. Increased dopamine release in the nucleus accumbens of copulating male rats as evidenced by in vivo voltammetry. Neurosci Lett 1990; 110: 303-308.
25. Heffner TG, Hartman JA, Seiden LS. Feeding increases dopamine metabolism in the rat brain. Science 1980; 208: 1168-1170.
26. Carlezon Jr WA, Wise RA. Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 1996; 16: 3112-3122.
27. Maldonado-Irizarry CS, Swanson CJ, Kelley AE. Glutamate receptors in the nucleus accumbens shell control feeding behavior via the lateral hypothalamus. J Neurosci 1995; 15: 6779-6788.
28. Kelley AE, Smith-Roe SL, Holahan MR. Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core. Proc Natl Acad Sci USA 1997; 94: 12174-12179.
29. Maldonado-Irizarry CS, Kelley AE. Excitotoxic lesions of the core and shell subregions of the nucleus accumbens differentially disrupt body weight regulation and motor activity in rat. Brain Res Bull 1995; 38: 551-559.
30. Frost JJ, Rosier AJ, Reich SG, Smith JS, Ehlers MD, Snyder SH et al. Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35 reveals marked declines in mild Parkinson's disease. Ann Neurol 1993; 34: 423-431.
31. Yagi S, Yoshikawa E, Futatsubashi M, Yokokura M, Yoshihara Y, Torizuka T et al. Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET. J Nucl Med 2010; 51: 1250-1257.
32. Ouchi Y, Yagi S, Yokokura M, Sakamoto M. Neuroinflammation in the living brain of Parkinson's disease. Parkinsonism Relat Disord 2009; 15(Suppl 3): S200-S204.
33. Jahanshahi M, Jones CR, Zijlmans J, Katzenschlager R, Lee L, Quinn N et al. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease. Brain 2010; 133(Part 3): 727-745.
34. Kringelbach ML. The human orbitofrontal cortex: linking reward to hedonic experience. Nat Rev Neurosci 2005; 6: 691-702.
35. Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994; 50: 7-15.
36. Lee KH, Blaha CD, Garris PA, Mohseni P, Horne AE, Bennet KE et al. Evolution of deep brain stimulation: human electrometer and smart devices supporting the next generation of therapy. Neuromodulation 2009; 12: 85-103.
37. Walker HC, Watts RL, Guthrie S, Wang D, Guthrie BL. Bilateral effects of unilateral subthalamic deep brain stimulation on Parkinson's disease at 1 year. Neurosurgery 2009; 65: 302-309, discussion 309-10.